Table 4.

Top 10 underlying conditions with risk association to COVID-19 mortality

Underlying conditions	Insured person (statutory scheme)	Hospitalisation	Ventilation	Death
Trisomies, behavioural and developmental disorders	439,231	2.09*** (1.59–2.75)	2.18* (1.03–4.61)	5.73*** (3.55–9.27)
Dementia and organic psychoorganic syndromes	362,189	2.23*** (1.98–2.51)	2.11*** (1.60–2.78)	5.54*** (4.57–6.72)
(Metastasised) malignant neoplasms	211,613	1.99*** (1.66–2.38)	1.60* (1.00–2.54)	3.85*** (2.80–5.29)
Haematological neoplasms	243,932	1.68*** (1.42–2.00)	2.40*** (1.69–3.41)	2.95*** (2.15–4.04)
Mental illnesses	1,576,220	1.70*** (1.51–1.92)	2.02*** (1.45 – 2.82)	2.86*** (2.16–3.79)
Severe kidney disease, dialysis	335,354	2.15*** (1.89–2.45)	2.37*** (1.80–3.14)	2.83*** (2.18–3.67)
HIV Tuberculosis Systemic mycoses	67,885	1.47 (0.96–2.26)	3.35*** (1.65–6.79)	2.62** (1.15–5.98)
Cirrhosis of the liver Liver failure	184,728	1.23 (0.99–1.54)	1.36 (0.84–2.20)	2.32*** (1.62–3.33)
Infections with multi-resistant germs/opp. Pathogens	439,231	1.51*** (1.26–1.81)	1.79** (1.22–2.62)	2.26*** (1.65–3.10)
Severe neurological diseases	362,189	1.72*** (1.46–2.01)	1.45 (0.95–2.20)	2.16*** (1.58–2.94)

For the underlying condition definition used here, please refer to the allocation table published. The complete list of underlying conditions is available in the results table, which has also been published

*pr( >|z|) < 0.05; **pr( >|z|) < 0.025; ***pr( >|z|) < 0.001; alpha-95% confidence interval in parentheses